Rotational Atherectomy for Calcified lEsion By Smart Angioplasty Research Team (SMART-RACE)
SMart Angioplasty Research Team: A Multi-center, Open Study to Evaluation the Efficacy and Safety of Rotational Atherectomy With Drug Eluting Stent for Calcified LEsion in Korea (SMART-RACE) Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Recruiting
- Hyoen-Cheol Gwon, MD,PhD
-
Contact:
- Hyoen-Cheol Gwon, MD,PhD
- Phone Number: 82-2-3410-3418
- Email: hcgwon@skku.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject must be at least 19 years of age
- Angiographically proven coronary artery disease
- Patients underwent Rotational Atherectomy
- He/she or his/her legally authorized representative provides written informed consent
- Target lesion(s) must be located in a native coronary artery with visually estimated diameter of ≥ 2.25 mm and ≤ 4.25 mm
Exclusion Criteria:
- Cardiac arrest before the procedure
- Pregnancy or breast feeding
- Thrombotic lesion
- Saphenous vein graft
- Unprotected left main lesion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Device : Rotablator
We compare in-hospital and long-term efficacy or safety of elective Rotational Atherectomy versus bailout Rotational Atherectomy and low-volume operator versus high-volume operator in patients with severe calcified lesions treated.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
A composite procedure-related complication
Time Frame: 2 years
|
cardiac death, peri-procedural myocardial infarction (CK-MB rise > X10 URL), coronary perforation, cardiopulmonary resuscitation, hemodynamic support (IABP, PCPS), or emergency surgery
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedure duration
Time Frame: from guiding catheter to final angiography, an average of 1 day
|
from guiding catheter to final angiography, an average of 1 day
|
|
|
Fluoroscopy time
Time Frame: from guiding catheter to final angiography, an average of 1 day
|
from guiding catheter to final angiography, an average of 1 day
|
|
|
Target vessel failure
Time Frame: 1,6 and 12months
|
Defined as a composite of cardiac death, myocardial infarction , or target vessel revascularization
|
1,6 and 12months
|
|
Final in-stent minimal lumen area by IntraVascular UltraSound
Time Frame: 1,6 and 12months
|
1,6 and 12months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2015-06-157
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.